ViiV Thinks It May Get All-Gender Approval For Cabotegravir For PrEP

 
• By Joseph Haas
  
PrEp tablet. Vector pre-exposure prophylaxis blue pill developed to prevent HIV epidemic.
ViiV hopes it will join Gilead in the HIV PrEP space with cabotegravir

More from Strategy

More from Business